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The leukotoxin (LktA) from Pasteurella haemolytica and the hemolysin (AppA) from Actinobacillus
pleuropneumoniae are members of a highly conserved family of cytolytic proteins produced by gram-negative
bacteria. Despite the extensive homology between these gene products, LktA is specific for ruminant leukocytes
while AppA, like other hemolysins, lyses erythrocytes and a variety of nucleated cells, including ruminant
leukocytes. Both proteins require activation facilitated by the product of an accessory repeat toxin (RTX) C
gene for optimal biological activity. We have constructed six genes encoding hybrid toxins by recombining
domains of ItkA and appA and have examined the target cell specificities of the resulting hybrid proteins. Our
results indicate that the leukocytic potential of AppA, like that of LktA, maps to the C-terminal half of the
protein and is physically separable from the region specifying erythrocyte lysis. As a consequence, we were able
to construct an RTX toxin capable of lysing erythrocytes but not leukocytes. The specificity of one hybrid
was found to be dependent upon the RTX C gene used for activation. With appC activation, this hybrid toxin
lysed both erythrocytes and leukocytes, while IkiC activation produced a toxin which could attack only
leukocytes. This is the first demonstration that the specificity of an RTX toxin can be determined by the process
of C-mediated activation.
A number of pathogenic gram-negative bacteria secrete
high-molecular-weight (100,000 to 110,000) calcium-depen-
dent cytolytic proteins which are immunologically and ge-
netically related to the alpha-hemolysin (HlyA) of Esche-
richia coli (7, 11, 17, 18, 21, 23-26). These toxins have been
designated the repeat toxin (RTX) family on the basis of a
series of glycine-aspartic acid-rich nonapeptide repeats
found in the carboxyl-terminal third of the toxin protein (33).
The genetic determinants for the secreted RTX toxins con-
sist of four genes: A, the structural gene for toxin protein; C,
which is required for activation of the toxin prior to secre-
tion; and BD, which are necessary for the process of
secretion. The four RTX genes are typically found in a single
transcriptional unit, CABD, and are expressed from a com-
mon promoter located upstream of the C gene (19, 34, 38). In
Actinobacillus pleuropneumoniae, however, the CA and BD
gene pairs are unlinked and appear to have been derived
from distinct RTX determinants (8).
The RTX toxins have been divided into two functionally
distinct classes: the hemolysins, which lyse erythrocytes in
addition to a variety of nucleated cell types, and the leuko-
toxins, which are lethal only to leukocytes. Within the
leukotoxin class, species specificity is also observed, since
the toxin produced by Actinobacillus actinomycetemcomi-
tans attacks only primate leukocytes (31), while that of
Pasteurella haemolytica is specific for ruminant leukocytes
(30). The molecular basis of the species and cell type
specificities of the RTX toxins is unknown. Comparisons of
the predicted amino acid sequences derived from the two
cloned leukotoxin genes and the cloned hemolysin genes
from E. coli and A. pleuropneumoniae have not revealed
* Corresponding author.
regions of homology which might account for the differing
specificities of the two RTX classes (23). This analysis has
identified two domains common to all known RTX toxins.
One lies in the N-terminal half of the toxin protein and
consists of four hydrophobic regions which may be involved
in forming channels in target membranes (28). The second
consists of a variable number (9 to 14) of the nonapeptide
repeats which are believed to constitute a calcium-binding
domain (4, 27). It is generally accepted that calcium is
required for the biological activity of these toxins (3, 10, 27).
Genetic experiments have demonstrated the existence of a
third domain at the extreme carboxyl terminus of the RTX
toxins (13, 14, 16, 22). This domain functions as a signal
which is recognized by the RTX BD-dependent secretion
pathway to direct transport of the toxin protein across the
bacterial envelope. Despite the fact that the carboxyl-termi-
nal domains of the RTX toxins are quite divergent in their
amino acid sequences, the cloned BD genes appear to be
interchangeable with respect to secretion of the RTX toxins
from E. coli (5, 15).
Until recently, no function had been ascribed to the
central region of the RTX proteins between the hydrophobic
and nonapeptide repeat domains which constitutes 40% of
the molecule. Recently, Forestier and Welch have demon-
strated that a monoclonal antibody which recognizes only
the activated form of HlyA binds to an epitope which maps
just amino proximal to the beginning of the repeat domain
(12). The existence of this antibody suggests that the HlyC-
mediated activation of HlyA involves covalent modification
of the HlyA protein. This undefined modification is essential
for the binding of HlyA to erythrocytes (4). The HlyC
protein has been shown to activate the AppA hemolysin
from A. pleuropneumoniae (15) and the LktA leukotoxin
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from P. haemolytica (12). In contrast, the LktC protein was
found to be incapable of activating HlyA (12), indicating
that, unlike the BD genes, the RTX C genes are not inter-
changeable. Deletion analysis of the lktA gene has demon-
strated that the region of LktA between the hydrophobic and
nonapeptide repeat domains is responsible for its ability to
bind productively to target leukocytes and is likely to
determine its specificity (9, 10). Although the boundaries of
this cell-binding domain have not been precisely delineated,
this domain begins near codon 548 of lktA and may extend
into or beyond the repeat region. Thus, evidence from both
the HlyA and LktA systems suggests that the central third of
the RTX toxins is required for binding to target cells and
represents the fourth functional domain described for these
proteins.
Given the high degree of similarity between the amino acid
sequences and proposed domain structures of the RTX
toxins, it should be possible to construct hybrid RTX A
genes from which biologically active proteins are expressed.
Such hybrids between an RTX hemolysin and an RTX
leukotoxin gene would allow further definition of the do-
main(s) involved in toxin-cell interaction which is responsi-
ble for the differing specificities of the two RTX classes.
Toward this end, we have constructed a series of hybrids
between the appA gene of A. pleuropneumoniae and the lktA
gene of P. haemolytica, which are nearly the same length
(956 and 953 codons, respectively) and share 64% identity at
the amino acid level (7, 23). We have chosen these genes in
order to maximize the likelihood of obtaining functional
hybrids. The biological activities and C dependence of the
hybrids reveal new features of the internal organization of
the RTX A genes and the process of their activation by RTX
C proteins.
MATERIALS AND METHODS
Bacterial strains and culture conditions. The E. coli host
TB1 (20) was used for the preparation of lysates containing
the wild-type and hybrid toxins employed in this study.
Bacteria were grown in Luria-Bertani medium (10 g of
tryptone, 10 g of NaCl, and 5 g of yeast extract per liter)
supplemented with ampicillin (50 ,ug/ml) and/or kanamycin
(50 ,ug/ml) when necessary. The bovine lymphoma cell line
BL3 was grown in Leibovitz L-15 medium with glutamine
(GIBCO Laboratories) containing 2.5% colostrum-free bo-
vine serum (GIBCO Laboratories) and 2.5% calf serum
(GIBCO Laboratories).
Plasmid manipulations. All plasmids used in this study
were derived from the lktCA clone pYFC19 (6) and the
appCA clone pYFC37 (7). The appA gene contains unique
HindIII and Clal sites at nucleotides 1489 (Lys-497) and 2284
(Ile-762), respectively. The IktA gene contains a unique ClaI
site at nucleotide 2302 (Ile-768), and a HindIll site was
created at nucleotide 1477 (Lys-493) by site-directed muta-
genesis. The required single-base change does not alter the
amino acid sequence of the LktA protein. By using these
restriction sites to divide the A genes into three domains, a
total of six chimeric toxin genes were generated by exchang-
ing homologous restriction fragments between the appropri-
ate plasmid pairs. Each of the initial constructs and the two
parental plasmids had either appC or IktC upstream of the A
gene. To construct clones with defective or deleted C genes,
the appC genes were removed by digestion with EcoRI
(which cuts in the vector polylinker) and BclI (which cleaves
in the intergenic region between appC and appA). The
DNAs were then blunt ended with T4 DNA polymerase and
recircularized by ligation in the presence of an EcoRI linker
to regenerate an EcoRI site upstream of the A genes. The
lktC genes were removed by digestion with EcoRI (cutting in
the vector polylinker) and BglII, which cleaves at nucleotide
346 of the lktC gene. The DNAs were then treated as
described above for the removal of the appC genes. Deletion
alleles of the hybrids LAA, LAL, and LLA (see below) were
generated by removing the NaeI fragment encoding residues
34 to 378 of the hybrid proteins. In all cases, the A genes are
transcribed from the lac promoter of pHG165, which has a
copy number of 20 to 30 per cell (32).
The appC and lktC genes from pYFC37 and pYFC19 were
subcloned into the vector pAC18, which is a pl5A replicon
carrying a Kanr determinant and which has a copy number of
5 to 10 per cell (2). This vector is compatible with the vector
pHG165, which is used to carry the parental and hybrid A
genes. For appC, the 759-bp EcoRI-BclI fragment of
pYFC37 was cloned into the EcoRI and BamHI sites of
pAC18. For iktC, the 685-bp EcoRI-NaeI fragment from
pYFC19 was cloned into the EcoRI and SmaI sites of
pAC18. In both cases, the C genes are transcribed from the
lac promoter of pAC18.
Preparation of native and hybrid toxin proteins for bioas-
say. Although the parental and hybrid toxins are secreted
from E. coli strains expressing RTX BD genes, this process
is inefficient, with the majority of the toxin activity remain-
ing intracellular. Consequently, assays for biological activity
were performed with lysates of E. coli expressing the desired
CA gene pairs in the absence of BD gene function. E. coli
cells containing the desired plasmids or plasmid pairs were
grown overnight and then diluted in Luria-Bertani medium
containing the appropriate antibiotics the following morning.
At an optical density of 2.0 at 550 nm, cells were harvested
by centrifugation, resuspended in 3.5 ml of calcium saline (10
mM Tris, 10 mM CaC12, 0.8% NaCl [pH 7.4]), and disrupted
by passage through a French pressure cell. The lysates were
centrifuged at 100,000 x g for 1 h at 5°C to remove
particulate material, and the supernatants were stored frozen
prior to assay for hemolytic and leukotoxic activities.
Assay for toxin activity. Leukotoxin activity was measured
as previously described (10). BL3 cells were washed and
resuspended at a concentration of 2 x 106 to 3 x 106 cells per
ml in Hanks balanced salt solution (HBSS) (0.8% NaCl,
0.04% KCI, 0.1% glucose, 2.5 mM CaCI2, 10 mM N-2-
hydroxyethylpiperazine-N'-2-ethanesulfonic acid [HEPES]
[pH 7.4]). Aliquots of toxin were added to 1 ml of the cell
suspension and incubated for 1 h at 37°C. Cells were then
collected by centrifugation, resuspended in HBSS contain-
ing 0.05% neutral red, and incubated an additional hour at
37°C. The cells were then washed twice with HBSS and
lysed with 500 RI of Nonidet P-40 buffer (10 mM Tris HCI
[pH 7.5], 10 mM NaCl, 3 mM MgCl2, 0.5% Nonidet P-40).
The nuclei were pelleted by centrifugation at 13,000 x g for
5 min, the supernatant containing the released neutral red
was diluted in 0.5 ml of 0.1 M acetic acid, and the dye
concentration was determined by measuring the A545. All
results are expressed as percentages of the dye taken up by
cells which had not been exposed to toxin. In this way,
dose-response curves were generated for toxin-containing
and control lysates. These data, in conjunction with the
intensity of the toxin band on Western blots (immunoblots),
allow the relative specific activities of the hybrids and
parental toxins to be compared.
To determine hemolytic activity, aliquots of toxin were
added to 1 ml of a suspension of bovine erythrocytes (3 x 107
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FIG. 2. Western blot analysis of the hybrid toxins. Lysates
containing the P. haemolytica leukotoxin and the A. pleuropneumo-
niae hemolysin are shown in lanes 3 and 4. The remaining samples
are lysates containing LLA (lane 5), AAL (lane 6), ALL (lane 7),
LAL (lane 8), LAA (lane 9), and ALA (lane 10). Lane 2 is a control
lysate from the E. coli host, TB1, which does not contain an RTX A
gene. An equal amount of lysate protein was loaded in each lane.
Immunoreactive bands were detected as described in Materials and
Methods. The apparent molecular weights of prestained standards
from Sigma Chemical Company are shown on the left (in thou-
sands).
FIG. 1. Structures of the hemolysin-leukotoxin hybrid genes.
The solid, hatched, and open boxes above the parental leukotoxin,
LLL, show the locations of regions encoding the potential mem-
brane-spanning region, the calcium-binding repeat domain, and the
secretion signal, respectively. For the toxin genes, the open boxes
represent sequences derived from the Pasteurella leukotoxin and
the crosshatched boxes represent sequences from the Actinobacillus
hemolysin. The solid boxes flanking the toxin structural genes
represent incomplete copies of the parental C and B genes derived
from the starting plasmids pYFC19 and pYFC37.
to 4 x 107/ml) in HBSS adjusted to 10 mM CaC12. After
incubation for 1 h at 37°C, unlysed cells and erythrocyte
ghosts were pelleted by centrifugation, and the amount of
hemoglobin in the supernatant was determined by measuring
the A540. All results are expressed as percentages of the
maximal hemoglobin released by lysing cells with Triton
X-100.
SDS-PAGE and Western blotting. Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) was per-
formed as previously described by Altman et al. (1). Immu-
noreactive proteins were detected after transfer to
nitrocellulose (35) with a mixture of bovine antileukotoxin
(6) and swine antihemolysin (7) as the first antibody and a
mixture of alkaline phosphatase-conjugated anti-bovine im-
munoglobulin G and anti-swine immunoglobulin G (Kirkeg-
aard & Perry Laboratories, Gaithersburg, Md.).
RESULTS
Construction and characterization of the hybrid toxins. The
appA gene can be divided into three domains by using
landmark restriction sites, as follows: domain I, from the
start codon to the HindIlI site at codon 497; domain II, from
codon 498 to the ClaI site at codon 762 between nonapeptide
repeats 5 and 6; and domain III, from codon 763 to the
carboxyl-terminal codon 956 (Fig. 1). A HindIII site was
created by a silent single-base change at the homologous site
in IkiA (codon 493), making it possible to divide this gene in
the same way (Fig. 1). The domain II-III junction of IktA
occurs between nonapeptide repeats 6 and 7. Each of the
three domains can be assigned distinct and separable func-
tions. Domain I contains the putative membrane-insertion
sequences required for target cell lysis by both AppA and
LktA (4, 26). Deletion analysis of lktA suggests that domain
II of this toxin is responsible for target cell (leukocyte)
specificity (10). Similar studies indicate that domain II of the
AppA hemolysin is involved in binding to leukocytes (36).
Domain III contains the carboxyl-terminal secretion signal
common to the RTX family (13, 14, 16, 22). By exchanging
these domains, six hybrid genes were constructed (Fig. 1).
For simplicity, each toxin used in this study is represented
by a three-letter acronym with A (for AppA) or L (for LktA)
to identify the source of each domain. Thus, AAA and LLL
are the parental toxins, while ALA is a hybrid with domains
I and III from AppA and domain II from LktA. Since the
ClaI site defining the boundary for domains II and III is not
at an equivalent site in the parental genes, the exact number
of repeats in the hybrid toxins varies. The parental toxins,
ALL, and LAA have 9 repeats, hybrids AAL and LAL have
8 repeats, and hybrids LLA and ALA have 10 repeats.
The parental genes and each of the hybrids were placed
under the transcriptional control of the lac promoter present
on the vector pHG165. Translation of the resulting mRNAs
relies on the translational start signals present in domain I.
Western blot analysis (Fig. 2) indicates that the parental and
hybrid LLA, LAL, AAL, and ALL toxin proteins were
recovered in approximately equal amounts; hybrids LAA
and ALA were recovered in 5- to 10fold-lower amounts.
Although the parental toxins differ in length by only 3 amino
acid residues and differ in predicted Mr by only 500 (AppA,
102,500; LktA, 102,000), the AppA protein has an apparent
molecular mass 3 to 4 kDa greater than that of LktA, as
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FIG. 3. Activation of the parental toxins by cognate and noncognate C proteins. Lysates were prepared from E. coli strains carrying the
desired plasmids and assayed for lytic activity against bovine BL3 leukemia cells or fresh bovine erythrocytes as described in Materials and
Methods. Each toxin protein was assayed without activation and with either AppC- or LktC-mediated activation. The nonspecific lytic
activity of E. coli lysates was determined with lysates prepared from cells harboring pHG165 and the pAC18 clone carrying either appC or
lktC. Symbols: O, toxin; A, toxin and LktC; 0, toxin and AppC; *, pHG165 and LktC; 0, pHG165 and AppC.
determined by SDS-PAGE (Fig. 2). Each of the hybrid
toxins was found to migrate between the two parental
proteins, suggesting that this anomaly is not uniquely deter-
mined by one of the three domains defined in this study.
Activation of the wild-type toxins by heterologous C genes.
Since it was not known whether the appC and lktC gene
products were functionally equivalent, it was necessary to
test each for the ability to activate the parental toxins, AppA
and LktA. As the data in Fig. 3 indicate, the appC gene was
capable of activating both toxins without alteration of target
cell specificities. In contrast, the lktC gene product could
only marginally activate AppA, giving toxin titers approxi-
TABLE 1. Lytic activities of the parental and hybrid toxins"
Hemolysin with: Leukotoxin with:
Toxin
appC lktC appC lktC
LLL h 20 10
AAA 10 5 500
LLA
LAA 30 70
LAL 40
AAL 20
ALL 100 30 5
ALA 60 500
" Data are expressed as the amount (micrograms) of lysate protein required
for 50% lysis (L50) of the input cells (107) after a 1-h incubation at 37'C. The
L50s are derived from titration curves similar to those shown in Fig. 3.b No activity above background levels. For erythrocyte lysis, the back-
ground level is typically 300 to 500 ,ug; for leukocyte lysis, the background
level is >4,000 ,ug.
mately 0.5% of that observed with AppC-activated AppA
against leukocytes (Fig. 3; Table 1). Because of the higher
background activity associated with the hemolysin assay, it
was not possible to determine whether LktC-activated AppA
displayed a similar, low hemolytic activity (nonspecific lysis
of erythrocytes by moderate amounts of cleared E. coli
lysates has been previously reported [37]). Lysates from E.
coli expressing lktA in the absence of RTX C gene function
were found to exhibit leukotoxin activity which was low (1%
of that observed with LktC activation) but reproducibly
above background levels (Fig. 3; Table 1). In contrast, AppA
protein synthesized in the absence of AppC appeared to be
lytically inactive (showing less than 0.1% of the activity
observed with AppC activation).
Novel phenotypes of the hybrid toxins. Surprisingly, recom-
binants LAL and AAL were found to have a target cell
specificity which differed from that of either of the parental
toxins. Upon activation by AppC, both hybrids were found
to lyse erythrocytes (Table 1) but had no detectable activity
against leukocytes (Table 1). Neither protein could be acti-
vated by LktC (Table 1). To reflect this new specificity, we
designate these two hybrids erythrocins (erythrocyte-spe-
cific toxins) to distinguish them from the hemolysins, which
lyse erythrocytes and leukocytes, and the leukotoxins,
which are leukocyte specific.
Hybrid ALL also displayed an unexpected phenotype.
When expressed in trans to appC, the toxin protein was
found to lyse both erythrocytes and leukocytes, as does the
parental AAA (Table 1). However, when activation was
mediated by LktC, ALL was strongly leukotoxic but not
erythrolytic (Table 1), as is the case with LktA. This is the
G)
0
C)9
c
100.
80 -
60 -
40.
20 .
J. BACTERIOL.
AAA
 o
n
 Septem
ber 21, 2018 by guest
http://jb.asm.org/
D
ow
nloaded from
 
TARGET CELL SPECIFICITIES OF AN RTX HEMOLYSIN 295
first indication that the target cell specificity of an RTX toxin
might be determined by the identity of the C protein respon-
sible for its activation. ALL was the only hybrid which could
be activated by the lktC gene product. Hybrid LAA was
found to be biologically indistinguishable from AppA
(AAA), with lytic activity toward both erythrocytes and
leukocytes only when activated by AppC (Table 1). Hybrid
ALA was similar to AppA except that the ratio of its lytic
activities toward leukocytes and erythrocytes was signifi-
cantly less than that of AppA (Table 1). Only one hybrid,
LLA, had no detectable activity when expressed alone or in
trans to either appC or lktC (Table 1).
Agglutinating phenotype of the hybrid toxins. We have
previously reported that the proteins expressed from certain
in-frame lktA deletion alleles are capable of agglutinating
bovine leukocytes in an LktC- and Ca2 -dependent fashion
(10). This agglutinating activity is seen only with deletions
which are restricted to the region encoding the hydrophobic
regions in the 5' half of the gene. Recently, we have found
that similarly deleted appA alleles also give rise to proteins
which agglutinate leukocytes (but not erythrocytes) in the
presence of Ca2+ (36). Thus, the carboxyl-terminal halves of
both the LktA and AppA proteins constitute autonomous
leukocyte-agglutinating domains whose interactions with
target cells can be investigated in the absence of cell lysis. In
order to determine whether the differing abilities of hybrids
LAA, LAL, and LLA to lyse BL3 cells reflect the functional
statuses of their leukocyte-agglutinating domains, we de-
leted the entire LktA-derived hydrophobic region of domain
I (codons 34 to 378) from these three hybrid alleles. The
identical deletion in lktA has been shown to yield a protein
which agglutinates, but does not lyse, bovine leukocytes
(10). The hybrid genes containing this deletion were then
expressed in trans to either appC or lktC and assessed for
the ability to agglutinate BL3 cells. The deletion protein
from LAA was found to agglutinate leukocytes only after
appC activation (Fig. 4). Since its parent was lytic toward
leukocytes only after appC activation, the ability of this
hybrid to lyse leukocytes correlates with the ability of the
carboxyl-terminal half of the protein to agglutinate this cell
type. The deletion proteins from LAL and LLA could not
agglutinate leukocytes after either appC or lktC activation
(Fig. 4), suggesting that they contain a defective leukocyte-
agglutinating domain. This is consistent with the inability of
either parent hybrid protein to lyse leukocytes.
DISCUSSION
Several studies have indicated that the HlyA protein is
devoid of hemolytic activity when expressed in an hlyC E.
coli host (12, 29). On the basis of these findings, it has been
widely assumed that the biological activity of all other RTX
proteins would also require modification by their cognate C
gene products. However, in an earlier report, Forestier and
Welch (12) showed that E. coli strains secreting the unmod-
ified LktA protein exhibited leukotoxicity levels greater than
background levels (see Table 1 in reference 12). In the
present study, we have found that the LktA protein which
accumulates intracellularly in a host without RTX CBD
function has an activity which is roughly 0.5 to 1.0% of that
observed for the same toxin synthesized in the presence of
an RTX C protein. One interpretation of this observation is
that LktA has an intrinsic lytic activity independent of C
activation. This would imply that C activation merely in-
creases the specific lytic activity of, or stabilizes, LktA.
Alternatively, this might indicate that there is a low level of
LktA activation in the absence of C function. In this case,
either the host provides a weak C-like activity or the RTX C
proteins normally facilitate a modification process which
involves host functions. These possibilities can be distin-
guished by a genetic analysis of the process of RTX A-pro-
tein activation.
While the AppC protein is able to activate both AppA and
LktA, the LktC protein can only weakly activate the non-
cognate toxin, AppA. Such nonreciprocal behavior has
previously been reported for the HlyC-LktC and HlyA-LktA
systems (12). In light of the ability ofAppC to activate LktA,
it is not surprising that AppC is capable of activating five of
the six hybrid toxins employed in this study. The one
exception, LLA, cannot be functionally activated by either
C protein. The only hybrid toxin activated by LktC has the
structure ALL, in which the C-terminal 460 residues are
derived from LktA. This may indicate that the junction
between domains II and III lies in a region of the protein
which is critical for recognition by LktC. When regions
flanking this junction are derived from AppA, activation by
LktC is not possible. The hybrid ALL is also peculiar in that
its specificity is determined by the nature of the C protein
used for activation. When coexpressed with appC, the ALL
protein is both erythrolytic and leukotoxic. However, acti-
vation by LktC produces a leukotoxin without detectable
erythrolytic activity. This is the first instance in which the
specificity of an RTX toxin has been shown to depend upon
the mode of its activation. We propose that while AppC and
LktC function similarly, they mediate modifications of the A
protein which differ in number or location along the A
polypeptide chain.
With the exception of LLA, all of the hybrids displayed
erythrolytic activity. This suggests that there is sufficient
information present in either domain I or domain II of AppA
to endow a hemolysin-leukotoxin hybrid with erythrolytic
activity (for example, both ALL and LAL are hemolytic
proteins). In contrast, only hybrids in which domains II and
III are both derived from the same parent were found to
exhibit leukotoxic activity comparable to that of LktA and
AppA. The inability of AAL and LAL to lyse leukocytes is
probably not due to a failure of C activation, since these
hybrids were completely inactive when expressed in the
absence of a C gene but became active erythrocins when
coexpressed with appC. Furthermore, the AppC-activated
hybrid ALA exhibited erythrolytic and leukotoxic activities
approximately 25 and 1%, respectively, of those seen with
AppA. Thus, C activation can have differential effects on the
leukotoxic and erythrolytic potentials of an RTX toxin, a
phenomenon which may explain the phenotype of hybrids
AAL and LAL. The erythrocins AAL and LAL also differ
from the parental toxins in that each contains one fewer
Gly-Asp repeat. These repeats constitute the calcium-bind-
ing region of the RTX toxins (4) and are essential for their
lytic activity (3, 10). It is possible that the altered repeat
region is responsible for the absence of leukotoxic activity
for AAL and LAL. If this is true, the effect of the altered
repeat region does not extend to the erythrolytic activity of
these hybrids, which is easily assayed and remains calcium
dependent.
We have previously shown that the carboxyl-terminal
halves of AppA (36) and LktA (10) are capable of aggluti-
nating BL3 cells. When the lytic domains of hybrids LAL
(erythrocin), LAA (hemolysin), and LLA (nonlytic) were
removed, only the deletion protein derived from LAA dis-
played the agglutinating phenotype characteristic of similar
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FIG. 4. Hybrid LAA contains a leukocyte agglutination domain. Lysates were prepared from E. coli strains expressing the appC gene and
either the wild-type appA gene or the domain I deletion alleles of LAA, LAL, or LLA. The lysates were incubated with BL3 leukemia cells
under standard assay conditions and examined for lysis or agglutination by phase-contrast microscopy as previously described (10). (A)
AppC-activated AppA; (B through D) AppC-activated deletions of LLA, LAL, and LAA, respectively. Magnification, ca. x 150.
deletion alleles of the parental toxins. Thus, the ability of the
C-terminal halves of AppA, LktA, and the hybrids described
in this study to agglutinate BL3 cells appears to be correlated
with the ability of these proteins to lyse leukocytes and is
unrelated to erythrolytic potential. Taken together, our
findings imply that (i) the hemolytic and leukotoxic poten-
tials of AppA are determined by different, but perhaps
overlapping, regions of toxin protein which respond differ-
ently to AppC and LktC activation, (ii) the erythrolytic
activity of AppA is specified by functionally independent or
redundant elements found in both domains I and II of the
protein, and (iii) the leukotoxic activity of LktA and AppA
requires specific interactions between domains II and III of
the toxins which occur only when both domains are derived
from the same parent.
ACKNOWLEDGMENTS
We are grateful to Lydia McCartney for administrative assistance,
M. Craig Miller and Roger Livingston for technical assistance, and
the Biomedical Communications Office of the College of Medicine
for photographic services.
J. BACTERIOL.
 o
n
 Septem
ber 21, 2018 by guest
http://jb.asm.org/
D
ow
nloaded from
 
TARGET CELL SPECIFICITIES OF AN RTX HEMOLYSIN 297
This work was supported by an AUF grant from the Texas A&M
University System (to R.Y.) and USDA grant 88-37266-3926 (to
R.Y. and D.K.S.).
REFERENCES
1. Altman, E., R. K. Altman, J. M. Garrett, R. J. Grimaila, and R.
Young. 1983. S gene product: identification and membrane
localization of a lysis control protein. J. Bacteriol. 155:1130-
1137.
2. Benedik, M. 1990. Personal communication.
3. Boehm, D. F., R. A. Welch, and I. S. Snyder. 1990. Calcium is
required for binding of Escherichia coli hemolysin (HlyA) to
erythrocyte membranes. Infect. Immun. 58:1951-1958.
4. Boehm, D. F., R. A. Welch, and I. S. Snyder. 1990. Domains of
Escherichia coli hemolysin (HlyA) involved in binding of cal-
cium and erythrocyte membranes. Infect. Immun. 58:1959-
1964.
5. Chang, Y.-F., R. Young, T. L. Moulds, and D. K. Struck. 1989.
Secretion of the pasteurella leukotoxin by Escherichia coli.
FEMS Microbiol. Lett. 60:169-174.
6. Chang, Y.-F., R. Young, D. Post, and D. K. Struck. 1987.
Identification and characterization of the Pasteurella haemolvt-
ica leukotoxin. Infect. Immun. 55:2348-2354.
7. Chang, Y.-F., R. Young, and D. K. Struck. 1989. Cloning and
characterization of a hemolysin gene from Actinobacillus (Hae-
mophilus) pleuropneumoniae. DNA 8:635-647.
8. Chang, Y.-F., R. Young, and D. K. Struck. 1991. The Actino-
bacillus pleuropneumoniae hemolysin determinant: unlinked
appCA and appBD loci flanked by pseudogenes. J. Bacteriol.
173:5151-5158.
9. Cruz, W. T., and D. K. Struck. Unpublished data.
10. Cruz, W. T., R. Young, Y.-F. Chang, and D. K. Struck. .1990.
Deletion analysis resolves cell-binding and lytic domains of the
Pasteurella leukotoxin. Mol. Microbiol. 4:1933-1939.
11. Felmlee, T., S. Pellett, and R. A. Welch. 1985. Nucleotide
sequence of an Escherichia coli chromosomal hemolysin. J.
Bacteriol. 163:94-105.
12. Forestier, C., and R. A. Welch. 1990. Nonreciprocal comple-
mentation of the hlyC and lktC genes of the Escherichia coli
hemolysin and Pasteurella haemolytica leukotoxin determi-
nants. Infect. Immun. 58:828-832.
13. Gray, L., K. Baker, B. Kenny, N. Mackman, R. Haigh, and I. B.
Holland. 1989. A novel C-terminal signal sequence targets
Escherichia coli haemolysin directly to the medium. J. Cell Sci.
Suppl. 11:45-57.
14. Gray, L., N. Mackman, J. M. Nicaud, and I. B. Holland. 1986.
The carboxyl-terminal region of haemolysin 2001 is required for
secretion of the toxin from Escherichia coli. Mol. Gen. Genet.
205:127-133.
15. Gygi, D., J. Nicolet, J. Frey, M. Cross, V. Koronakis, and C.
Hughes. 1990. Isolation of the Actinobacillus pleuropneumoniae
haemolysin gene and the activation and secretion of the prohae-
molysin by the HlyC, HlyB and HlyD proteins of Escherichia
coli. Mol. Microbiol. 4:123-128.
16. Hess, J., I. Gentschev, W. Goebel, and T. Jarchau. 1990.
Analysis of the haemolysin secretion system by PhoA-HlyA
fusion proteins. Mol. Gen. Genet. 224:201-208.
17. Hess, J., W. Wels, M. Vogel, and W. Goebel. 1986. Nucleotide
sequence of a plasmid-encoded hemolysin determinant and its
comparison with a corresponding chromosomal hemolysin se-
quence. FEMS Microbiol. Lett. 34:1-11.
18. Highlander, S. K., M. Chidambaram, M. J. Engler, and G. M.
Weinstock. 1989. DNA sequence of the Pasteurella haelnolytica
leukotoxin gene cluster. DNA 8:15-28.
19. Highlander, S. K., M. J. Engler, and G. M. Weinstock. 1990.
Secretion and expression of the Pasteutrella haemolytica leuko-
toxin. J. Bacteriol. 172:2343-2350.
20. Johnston, T. C., R. B. Thompson, and T. 0. Baldwin. 1986.
Nucleotide sequence of the luxB gene of Vibrio haveyi and the
complete amino acid sequence of the beta subunit of bacterial
luciferase. J. Biol. Chem. 261:4805-4811.
21. Koronakis, V., M. Cross, B. Senior, E. Koronakis, and C.
Hughes. 1987. The secreted hemolysins of Proteus mirabilis,
Proteus vulgaris, and Morganella morganii are genetically
related to each other and to the alpha-hemolysin of Escherichia
coli. J. Bacteriol. 169:1509-1515.
22. Koronakis, V., E. Koronakis, and C. Hughes. 1989. Isolation and
analysis of the C-terminal signal directing export of Escherichia
coli hemolysin across both bacterial membranes. EMBO J.
8:595-605.
23. Kraig, E., T. Dailey, and D. Kolodrubetz. 1990. Nucleotide
sequence of the leukotoxin gene from Actinobacillus actino-
mnycetemcomitans: homology to the alpha-hemolysin/leuko-
toxin gene family. Infect. Immun. 58:920-929.
24. Lally, E. T., E. E. Golub, I. R. Kieba, N. S. Taichman, J.
Rosenblum, J. C. Rosenblum, C. W. Gibson, and D. R. Demuth.
1989. Analysis of the Actinobacillus actinomycetemcomitans
leukotoxin gene. J. Biol. Chem. 264:15451-15456.
25. Lo, R. Y. C., P. E. Shewen, C. A. Strathdee, and C. N. Greer.
1985. Cloning and expression of the leukotoxin gene of Pas-
teutrella haemolvtica Al in Escherichia coli K-12. Infect. Im-
mun. 50:667-671.
26. Lo, R. Y. C., C. A. Strathdee, and P. E. Shewen. 1987.
Nucleotide sequence of the leukotoxin genes of Pasteurella
haemnolytica Al. Infect. Immun. 55:1987-1996.
27. Ludwig, A., T. Jarchau, R. Benz, and W. Goebel. 1988. The
repeat domain of E. coli haemolysin (hlyA) is responsible for its
Ca++-dependent binding to erythrocytes. Mol. Gen. Genet.
214:553-561.
28. Ludwig, A., M. Vogel, and W. Goebel. 1987. Mutations affecting
the activity and transport of haemolysin in Escherichia coli.
Mol. Gen. Genet. 206:238-245.
29. Nicaud, J.-M., N. Mackman, L. Gray, and I. B. Holland. 1985.
Characterization of HlyC and the mechanism of activation and
secretion of haemolysin from E. coli 2001. FEBS Lett. 187:339-
344.
30. Shewen, P. E., and B. N. Wilkie. 1982. Cytotoxin of Pasteurella
haemolytica acting on bovine leukocytes. Infect. Immun. 35:
91-94.
31. Simpson, D. L., P. Berthold, and N. S. Taichman. 1988. Killing
of human myelomonocytic leukemia and lymphocytic cell lines
by Actinobacillus actinomycetemcomitans leukotoxin. Infect.
Immun. 56:1162-1166.
32. Stewart, G. S., S. Luchinsky-Mink, C. A. Jackson, A. Cassel,
and J. Kuhn. 1986. pHG165: a pBR322 copy number derivation
of pUC8 for cloning and expression. Plasmid 15:172-186.
33. Strathdee, C. A., and R. Y. C. Lo. 1989. Cloning, nucleotide
sequence, and characterization of genes encoding the secretion
function of the Pasteurella haemolytica leukotoxin determinant.
J. Bacteriol. 171:916-928.
34. Strathdee, C. A., and R. Y. C. Lo. 1989. Regulation of expres-
sion of the Pasteurella haemolytica leukotoxin determinant. J.
Bacteriol. 171:5955-5962.
35. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic
transfer of proteins from polyacrylamide gels to nitrocellulose
sheets: procedure and some applications. Proc. Natl. Acad. Sci.
USA 76:4350-4354.
36. Tu, A. H., and D. K. Struck. Unpublished data.
37. Wagner, W., M. Kuhn, and W. Goebel. 1988. Active and
inactive forms of hemolysin (HlyA) from Escherichia coli. Biol.
Chem. Hoppe-Seyler 369:39-46.
38. Welch, R. A., and S. Pellett. 1988. Transcriptional organization
of the Escherichia coli hemolysin genes. J. Bacteriol. 170:1622-
1630.
VOL. 174, 1992
 o
n
 Septem
ber 21, 2018 by guest
http://jb.asm.org/
D
ow
nloaded from
 
